Last reviewed · How we verify

NCT03460834

Asthma and Obesity: Observational

Completed Last updated 6 May 2021
What this trial tests

trial in Asthma in 333 participants. Completed in 30 April 2021.

Timeline
1 May 2016
Primary endpoint
30 April 2021
30 April 2021

Quick facts

Lead sponsorIcahn School of Medicine at Mount Sinai
StatusCompleted
Study typeOBSERVATIONAL
Enrollment333
Start date1 May 2016
Primary completion30 April 2021
Estimated completion30 April 2021
Sites2 locations across United States

Conditions studied

Sponsor

Icahn School of Medicine at Mount Sinai

Who can join

Adults 21 to 64, any sex, with Asthma or Obesity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Obesity is associated with poor asthma control and greater healthcare utilization and costs. In this study the researchers will examine the biologic and behavioral interrelationships between these conditions and their impact on outcomes. Towards this end, the researchers will conduct an observational prospective cohort study of 400 obese asthmatic patients treated at institutions in New York City and Denver, and develop and pilot test educational and counseling modules that take an integrated approach to asthma and obesity self-management support.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Asthma

Currently open trials in the same condition.

Other Icahn School of Medicine at Mount Sinai trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03460834.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing